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Background: The atrial gap junction protein connexin-40 (Cx40) has been implicated to play an important role in
atrial conduction and development of atrial fibrillation (AF). However, the frequency of Cx40 mutations in AF
populations and their impact on Cx40 expression remains unclear. In this study, we sought to identify
polymorphisms in the Cx40 gene GJA5, investigate the potential functional role of these polymorphisms, and
determine their allelic frequencies. The prevalence of nonsynonymous Cx40 mutations in blood and atrial tissue
was also compared to mutation frequencies reported in prior studies.
Methods: We conducted direct sequencing of the GJA5 coding and 30 UTR regions in blood samples from 91 lone
AF subjects and 67 atrial tissue-derived samples from a lone cohort, a mixed AF cohort, and several transplant
donors. Reporter gene transfection and tissue allelic expression imbalance assays were used to assess the effects of
a common insertion/deletion polymorphism on Cx40 mRNA stability and expression.
Results: We identified one novel synonymous SNP in blood-derived DNA from a lone AF subject. In atrial
tissue-derived DNA from lone and mixed AF subjects, we observed one novel nonsynonymous SNP, one rare
previously reported synonymous SNP, and one novel 30 UTR SNP. A previously noted 25 bp insertion/deletion
polymorphism in the 30 UTR was found to be common (minor allele frequency = 0.45) but had no effect on Cx40
mRNA stability and expression. The observed prevalence of nonsynonymous Cx40 mutations in atrial tissues derived
from lone AF subjects differed significantly (p = 0.03) from a prior atrial tissue study reporting a high mutation
frequency in a group of highly selected young lone AF subjects.
Conclusions: Our results suggest that Cx40 coding SNPs are uncommon in AF populations, although rare
mutations in this gene may certainly lead to AF pathogenesis. Furthermore, a common insertion/deletion
polymorphism in the Cx40 30 UTR does not appear to play a role in modulating Cx40 mRNA levels.
Keywords: Atrial fibrillation, Connexins, Ion channels, Genetics, Allelic expression imbalanceBackground
Atrial fibrillation (AF) is the most commonly encoun-
tered form of sustained cardiac arrhythmia in clinical
practice, with a prevalence in the USA that is projected
to increase three-fold between the years 2000 and 2050
[1-3]. AF is a complex disease characterized by irregular
electrical activity within the atria, resulting in episodes* Correspondence: smithj4@ccf.org
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reproduction in any medium, provided the orof uncoordinated atrial contraction that substantially in-
crease stroke risk and mortality [4-6]. Studies investigat-
ing the genetic basis of the disease have shown that
somatic and germ line variants in the atrial gap junction
protein connexin-40 (Cx40) can disrupt normal atrial
conduction and may predispose individuals to idiopathic,
or lone, AF [7-9]. The Cx40 gene GJA5 encodes two al-
ternative transcripts, Cx40-A and Cx40-B, comprised of
first exons 1A or 1B and a shared coding second exon,
respectively [10]. We previously described rs10465885, a
common single nucleotide polymorphism (SNP) in theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pression and is associated with early onset lone AF [11].
We hypothesized that direct sequencing of the GJA5 re-
gion in atrial and blood DNA from expanded cohorts of
mixed and lone AF patients might yield additional poly-
morphisms altering Cx40 structure or expression, poten-
tially resulting in a predisposition to AF.
Methods
Study subjects
Most (64 of 67) of the atrial appendage tissues were
obtained from a biorepository of human atrial tissues from
patients undergoing coronary artery bypass grafting, valve
surgery and/or the Maze surgical ablation procedure. Sub-
jects had a history of AF and were categorized as “lone
AF” if they did not have structural heart disease, or “mixed
AF” if they had AF in combination with coronary artery
disease or valvular heart disease (mitral regurgitation).
The remaining three atrial tissue samples were obtained
from non-failing donor hearts not used for transplant with
unknown cardiac phenotypes (Table 1). Use of discarded
atrial tissues from surgical subjects was approved with
an exemption for written consent by the Cleveland
Clinic Institutional Review Board and performed in ac-
cordance with institutional guidelines. Atrial specimens
were obtained from unmatched organ donor hearts,




Age, years, mean ± SD (range) 53.8 ± 9.6
(31–71)
Sex, male 28 (82.4)
Race, Caucasian 32 (94.1)















AF = atrial fibrillation, CAD = coronary artery disease, ND = not determined.and used under a protocol approved by the Cleveland
Clinic Institutional Review Board.
Blood samples were obtained from the Cleveland
Clinic Lone Atrial Fibrillation GeneBank (CCAF), which
enrolled subjects at least 18 years of age who had a his-
tory of AF without coronary heart disease. Specifically,
these subjects had no significant coronary artery disease
(<50% coronary artery stenosis if cardiac catheterization
was performed or a normal stress test) and normal left
ventricular function (left ventricular ejection fraction
≥50%). Patients were excluded if they had structural
heart disease or congenital heart disease, except for an
isolated patent foramen ovale with normal right heart
chambers; significant valvular disease (>2+ regurgitation
or any valve stenosis); or prior percutaneous coronary
intervention or coronary artery bypass grafting. Patients
with hypertension were not excluded. Written informed
consent was obtained from all CCAF subjects under a
protocol approved by the Cleveland Clinic Institutional
Review Board and performed in accordance with institu-
tional guidelines. There were no subjects from whom we
obtained both atrial tissue- and blood-derived DNA.
Preparation of genomic DNA, total RNA and
complementary DNA from human atrial tissue and blood
Atrial genomic DNA (gDNA) and total RNA was pre-
pared from atrial tissue samples using Qiagen kits.trial tissues Blood samples
Mixed AF Donor lone AF
N=30 (%) N=3 (%) N=91 (%)
66.3 ± 9.8 50 ± 15.6 57.8 ± 11.5
(32–86) (32–60) (25–84)
17 (56.7) 2 (67) 67 (73.6)
29 (96.7) 3 (100) 87 (95.6)







6 (20.0) 39 (42.9)
5 (16.7) 33 (36.3)
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Synthesis Kit (BioRad) using an oligo(dT)20 primer.
Buffy coat gDNA was prepared from blood samples of
subjects in the CCAF Genebank using the MasterPure
DNA Purification Kit for Blood Version II (Epicentre
Biotechnologies).
Firefly luciferase-GJA5 30 UTR Expression Vector
Construction
The GJA5 30 UTR region (1,938 bp) from atrial tissue
gDNA was amplified by PCR using the upstream primer
ATGATCTCGAGAAGCGACGTCTTAGTAAGGCCAG
and the downstream primer ATGCATGGGCCCCCTT-
TACCCATCCCATCAGCACC (XhoI and ApaI sites in
bold). PCR products were cloned into the pGEMT-easy
vector (Promega), transformed into DH5α Escherichia
coli, and screened for the presence of the insert. Wild-
type and variant GJA5 30 UTR insert sequences were
then directionally cloned into a modified pcDNA3-Luc
vector, immediately downstream of the luciferase coding
region. The resulting constructs were co-transfected into
HL-1 murine atrial cardiomyocytes [12] with a β-
galactosidase-containing transfection control vector, and
the Dual-Light reporter gene assay system (Tropix) was
used to measure luciferase and β-galactosidase activities
in cell lysates according to methods previously described
[11]. The mRNA instability positive control was gener-
ated by annealing the single-stranded oligos TCGA-
CATTTATTTATATTTATTTACCGCGCGGCGCCG
and TCGACGGCGCCGCGCGGTAAATAAATATAAA-
TAAATG, which contain an AU-rich element (ARE, bold
emphases) that reduces mRNA stability when present in
the 30UTR [13]. Annealed oligos were phosphorylated with
T4 polynucleotide kinase (M0201, NEB) and cloned into
the XhoI site of the GJA5 30 UTR luciferase reporter
described above.
GJA5 gDNA and cDNA Sequencing
Screening of 67 atrial derived gDNA samples for the 25
bp insertion/deletion polymorphism was carried out
using the PCR primers ATTCCTCGGAGTAGTGGT-
GAGATGG (upstream) and ACACCCTAGCAGAAG-
GAAAGGTTGC (downstream), which amplify a 131 bp
region in the GJA5 30 UTR. For sequencing of the GJA5
coding region in gDNA derived from blood or atrial tis-
sue, two overlapping fragments of GJA5 were amplified
using the primer pairs ACGAGTACCCGGTGGCAGA-
GAAGGC (upstream) and AGGAGCCAAGCAGTGAT-
GACAGTGAGAA (downstream) and GCTAATATGG-
CTACTTTGAATCTTCTC (upstream) and ACATGC-
AGGGTGGTCAGGAA (downstream), respectively. The
GJA5 PCR fragments were sequenced and analyzed for
SNPs using the SNP Analysis tool hosted by the La-
boratory of Population Genetics, National CancerInstitute, NIH (http://lpg.nci.nih.gov/LPG) [14]. To
measure allelic expression imbalance, we used a highly
sensitive sequencing technique that compares cDNA
and gDNA allelic ratios in heterozygous individuals
[15]. This is an adaptation of a similar technique using
single base extension that also compares allelic ratios in
cDNA vs. gDNA in heterozygous subjects [16,17]. A
Cx40-A fragment containing exon 1A, the coding
region and approximately 1 kb of the 30 UTR (including
the 25bp insertion/deletion and an indicator SNP
rs1043806) was amplified from eight atrial tissue-
derived cDNA samples using the PCR primers GGTGG
AAGAGGAACAACTGA (upstream) and GGGCCTCC
ATAGCTGTCATCA (downstream). A portion of the
GJA5 30 UTR containing the indicator SNP rs1043806
was amplified from gDNA using the PCR primers
ATTCCTCGGAGTAGTGGTGAGATGG (upstream) and
GGGCCTCCATAGCTGTCATCA (downstream). The
Cx40-A cDNA fragment and the gDNA GJA5 30 UTR
fragment corresponding to each subject were sequenced
using Sanger methodology on an Applied Biosystems
3730xl DNA analyzer. The sequence trace files were
analyzed using PeakPicker 2 software (publicly available
at http://genomequebec.mcgill.ca/publications/pastinen/)
[15] to determine the cDNA allelic expression ratio,
normalized to the gDNA ratio, at the rs1043806 pos-
ition as previously described [11].
Results
Patient Characteristics
Table 1 shows the demographics of 91 lone AF blood
donors and a separate group of 67 subjects who pro-
vided atrial tissue. Of the 67 atrial appendage
donors, 34 had lone AF (no significant structural
heart disease), 30 had AF with coronary artery dis-
ease or valvular heart disease (mitral regurgitation),
and 3 were derived from heart transplant donors
with limited phenotypic information. Approximately
half (56.7%) of the 67 tissue donors were in AF at
the time of surgery.
Single nucleotide polymorphisms in the connexin-40
coding region
In order to screen for and assess the frequency of nonsy-
nonymous Cx40 variants in a large cohort of subjects of
European ancestry, we conducted direct sequencing of
the Cx40 coding region in blood- and atrial tissue-
derived gDNA samples from patients diagnosed with
lone or mixed AF, as well as a small number of trans-
plant donors. Detected SNPs were determined to be
novel if they have not been previously reported in public
SNP databases, including those available from dbSNP
[18] and the Thousand Genomes Project [19]. Out of 34
atrial tissue samples obtained from lone AF patients
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SNP was identified (339G>C) (Figure 1A). The novel
339G>C SNP results in a substitution of serine for argin-
ine in the cytoplasmic loop of Cx40 (R113S) at a pos-
ition that is highly conserved in mammals. Analysis with
the PolyPhen-2 tool predicts that R113S is likely to be
functionally and structurally well-tolerated [20]. Since
blood samples matching our atrial tissue samples were
not available, we were unable to determine whether the
339G>C variant had a somatic or germline origin. No
novel SNPs were observed through direct sequencing of
33 atrial tissue samples from a mixed AF and donor co-
hort (Table 1). Sequencing of 91 blood samples from a
lone AF cohort (Table 1) yielded one novel synonymous
Cx40 coding SNP (951T>C, Figure 1B) and one previ-
ously reported synonymous coding SNP (rs2232191) in
separate individuals. A search in dbSNP shows that the
latter SNP is rare in the HapMap European and African
populations, but has an allele frequency of ~ 5% in the
Chinese and Japanese populations [18].Identification of variation in the proximal region of the 30
UTR
We conducted a search for novel regulatory variants of
GJA5 by sequencing the proximal 1,435 bp of the GJA5
30 UTR region in atrial tissue genomic DNA samples
from 48 patients diagnosed with AF, a subset of the 67
subjects described in Table 1. We observed a novel poly-
morphism 22 bp downstream of the stop codon
(*22G>A) in a single sample. We also observed a 25 bp
insertion/deletion in multiple subjects (Figure 2A-C).
The insertion/deletion, described in data uploaded byFigure 1 Sequence traces of novel Cx40 SNPs. (A) Sequence of 339G>C
sample. 339G>C results in the cytoplasmic loop substitution R113S. (B) Seq
AF blood sample.Levy and colleagues in the first reported human diploid
genome sequence, is located approximately 640 bp
downstream of the stop codon and approximately 1,300
bp upstream of the poly-A signal [21]. We developed a
PCR length polymorphism assay to screen for the inser-
tion/deletion in the full set of atrial gDNA derived from
67 tissue donors (Figure 2D), and we determined the
minor allele (insertion) frequency to be 0.45. We also
frequently observed the common 30 UTR SNP
rs1692141, located 53 bp downstream of the GJA5 stop
codon with a minor allele frequency of 0.237 in our
samples.Linkage disequilibrium of the GJA5 30 UTR insertion/
deletion
Haplotype analysis of the GJA5 30 UTR insertion/dele-
tion was conducted with the atrial tissue samples, exam-
ining eight SNP genotypes situated within the GJA5
region. The SNP genotypes tested consisted of the com-
mon Cx40-B promoter variant rs10465885, a Cx40-A
promoter SNP (rs11552588) and five other contiguous
GJA5 SNPs from the Illumina Hap550 BeadChip
[11,22,23]. One of these SNPs, rs1043806 in the GJA5 30
UTR, was used as the indicator SNP in an expression
imbalance assay, as described below. Analysis of linkage
disequilibrium (LD) relationships using Haploview v.4.1
(Broad Institute) determined that the insertion/deletion
polymorphism is in partial LD with rs10465885, with
r2 = 0.81 (Figure 3). We have previously shown that
rs10465885 is modestly associated with early onset lone
AF, exerting a strong cis-effect on atrial expression of
the Cx40-B transcript, and is also associated with atrial, a novel nonsynonymous Cx40 SNP identified in a lone AF atrial tissue
uence of 951T>C, a novel synonymous Cx40 SNP identified in a lone
Figure 2 Identification of a 25 bp insertion/deletion polymorphism in the GJA5 30 UTR. Sequence traces from human atrial gDNA from (A)
a deletion homozygote, (B) an insertion homozygote, and (C) a heterozygote are shown. Nucleotide sequence numbering is based on the GJA5
Refseq entry (NM_181703). (D) PCR assay of atrial gDNA from 15 individuals, identifying homozygotes for the insertion (upper band, 206 bp),
homozygotes for the deletion (lower band, 181 bp), and heterozygotes (with both bands). Screening of 67 atrial samples determined the minor
allele frequency of the insertion to be 0.45.
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that the insertion/deletion polymorphism might also
play a role in regulation of Cx40 expression.
Functional assay of the GJA5 30 UTR insertion/deletion
We designed a luciferase reporter assay to investigate
the potential effects of the common insertion/deletion
on Cx40 mRNA stability and/or translation. GJA5 30
UTR sequences containing the deletion, the insertion, or
a combination of the insertion and the 30 UTR variant
*22G>A were fused to the 30 end of the firefly luciferase
gene in a modified pcDNA3 vector [24]. The resulting
insertion/deletion constructs were transiently transfected
into HL-1 atrial murine cardiomyocytes and the cell
lysates were assayed for luciferase activity, normalized
for transfection efficiency. Comparable levels of activity
were observed for cells expressing each construct
(Figure 4A), suggesting that the insertion/deletion poly-
morphism is not associated with altered Cx40 tran-
slational efficiency or mRNA stability. As a positive
control, a luciferase reporter construct containing the
GJA5 30UTR sequence with the insertion polymorphism
was modified to include an AU-rich element (ARE) thathas been shown to decrease mRNA stability when
present in the 30UTR [13]. HL-1 murine cardiomyocytes
transfected with the ARE-GJA5 30UTR construct demon-
strated a 54% reduction in luciferase activity compared
to cells transfected with the unmodified reporter
(Figure 4B, p<0.05).
Allelic expression imbalance assay for the GJA5 30 UTR
insertion/deletion
The potential effect of the insertion/deletion on atrial
Cx40 mRNA levels was also tested using a previously
described allelic expression imbalance assay [11,16]. In
this assay, the relative expression of two allelic Cx40
transcripts was quantified by direct cDNA sequencing in
subjects heterozygous for a common indicator SNP con-
tained within the mRNA. PeakPicker 2 software [15,25]
was used to calculate the allelic ratios by measuring peak
heights from cDNA sequence traces, normalized to the
allelic ratio of the corresponding heterozygous gDNA.
Of the two alternatively spliced Cx40 transcripts, Cx40-
A mRNA expression was measured in order to exclude
the strong allelic imbalance observed for the Cx40-B
transcript in rs10465885 heterozygotes. We tested eight
Figure 4 The 30 UTR insertion/deletion polymorphism does not
significantly affect GJA5 mRNA stability or translational
efficiency. (A) HL-1 murine cardiomyocytes transfected with
vectors containing the firefly luciferase gene fused at its 30 end to
the GJA5 30 UTR were measured for luciferase activity, normalized
to the β-galactosidase activity of the transfection control vector.
Shown are the mean activities, ± standard deviations. No
significant differences in activity were observed for constructs
carrying the deletion (Del, n=8), the insertion (Ins, n=4), or the
insertion with a 30 UTR point mutation (Ins + *22G>A, n=4)
(P = 0.256, one-way ANOVA). (B) A GJA5 30 UTR construct carrying
the insertion was modified to include a mRNA instability sequence
upstream of the GJA5 30 UTR. The resulting positive control vector
(ARE-Ins) demonstrated reduced luciferase activity compared to
the unmodified vector (p<0.05, n=3).
Figure 3 Linkage disequilibrium of the GJA5 30 UTR insertion/
deletion. Linkage disequilibrium relationships (r2) between the
Cx40-B promoter SNP (rs10465885), a Cx40-A promoter SNP
(rs11552588), the 30 UTR SNP (rs1043806) used for the allelic
expression imbalance assay, the insertion deletion polymorphism
(Ins/Del), and four other GJA5 SNPs from the Illumina Hap550
BeadChip. The positions of the SNPs relative to the alternative
transcripts for Cx40-A and Cx40-B are displayed. The D0 between
rs1043806 and the insertion/deletion is 1.0 (not shown).
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tion and the indicator SNP rs1043806. The minor G al-
lele of rs1043806 is in partial LD with the insertion/
deletion (r2 = 0.31, Figure 3) and is consistently in phase
with the deletion allele (D' = 1.0). Six of the eight sam-
ples demonstrated weak allelic expression imbalance,
yielding a mean 1.56-fold increase in Cx40 expression
for the deletion-G allele (Figure 5). The remaining two
samples showed no change in Cx40 levels or imbalance
in the opposite direction, respectively (Figure 5), yielding
an overall mean 1.39-fold increase for the deletion-G al-
lele. The observed pattern of incomplete expression im-
balance indicates that the insertion/deletion is not
directly associated with regulation of Cx40 expression;
however, the insertion/deletion polymorphism may be in
partial LD with a separate unidentified modest-strength
regulatory variant.
Statistical analyses of Cx40 missense allele frequencies in
human blood and atrial tissue
Fisher’s exact probability test was used to compare the
frequencies of nonsynonymous variant Cx40 alleles
observed in our studies with those reported by groups
studying similar sample cohorts. We found no statisti-
cally significant difference (p = 0.56) between the fre-
quency of missense Cx40 alleles in our 91 lone AF blood
samples (variant:non-variant alleles = 0:182, 0%) and the
frequency observed in 218 lone AF blood samples byYang and colleagues (3:433, 0.69%) [26]. However, we
observed a significant difference (p = 0.03) when com-
paring Cx40 missense allele frequencies in our 34 lone
AF tissues (average age at surgery 54 years), in which we
detected a single nonsynonymous variant (variant:non-
variant alleles = 1:67, 1.47%), and the frequency observed
by Gollob et al. in 15 highly selected and young (average
age of onset 45 years) lone AF tissue donors, in which
four novel heterozygous Cx40 missense mutations were
found (4:26, 13.3%) [9].
Figure 5 Allelic expression imbalance analysis of Cx40-A mRNA.
Shown are eight atrial tissue samples heterozygous for the GJA5 30
UTR insertion/deletion polymorphism and the indicator SNP
rs1043806. Each bar represents the allelic expression ratio for an
individual subject, based on peak heights for cDNA/gDNA at the
indicator SNP site. Significant allelic mRNA imbalance is found when
the cDNA allelic ratio falls outside of a 95% confidence interval
created by the gDNA allelic ratios (dotted lines). The G allele of the
indicator SNP was always found together with the deletion allele of
the insertion/deletion polymorphism. Six samples demonstrated
weak allelic expression imbalance of Cx40 favoring the deletion-G
allele. One sample was not significantly associated with allelic
expression imbalance and another sample exhibited Cx40 expression
imbalance in the opposite direction.
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We conducted direct sequencing of the GJA5 coding re-
gion in 91 lone AF blood samples and 67 atrial tissue
samples (34 lone AF, 30 mixed AF, and 3 donors) from
individuals of predominantly European ancestry, identi-
fying a novel nonsynonymous SNP (339G>C), a novel
synonymous SNP (951T>C), and a previously reported
synonymous SNP (rs2232191). In the 30 UTR we identi-
fied a single novel variant (*22G>A). We also deter-
mined that a 25 bp insertion/deletion polymorphism in
the GJA5 30 UTR is common and in partial LD with the
Cx40 transcript B promoter SNP rs10465885, which is
associated with early onset lone AF and strongly corre-
lated with Cx40-B and total Cx40 expression [11]. How-
ever, reporter gene transfection and Cx40-A allelic
expression imbalance assays indicated that the insertion/
deletion is not directly associated with changes in Cx40
expression. The modest and inconsistent 1.39-fold effect
observed for the insertion/deletion in the 8 subjects
assayed for Cx40-A allelic expression imbalance was
much weaker than the consistent 3.3-fold effect that
rs10465885 has on allelic expression imbalance of the
Cx40-B transcript [11]. These allelic expression imbal-
ance results support the hypothesis that the insertion/
deletion is in partial LD with a separate modestregulatory variant that is responsible for the partial allelic
imbalance observed.
The most recent and largest AF genome-wide associ-
ation study has not identified common variants in or
near the GJA5 gene to be associated with AF at the con-
servative genome-wide significance threshold [27]. How-
ever, we have previously identified a common GJA5
promoter variant that both alters Cx40 expression levels
and is weakly associated with AF [11]. Since not all of
the heritability for common traits can be attributed to
common variants, sequencing studies can be used to
identify rare variants that may contribute to AF suscepti-
bility. Recent sequencing studies screening lone AF
patients for novel Cx40 coding variants have observed
very different rare allele frequencies. In fifteen young,
idiopathic AF patients of Western European descent,
Gollob et al. identified one germ line and three somatic
nonsynonymous variants in the Cx40 coding region
using DNA derived from atrial tissue samples and blood
[9]. In contrast, we observed only one nonsynonymous
variant in our 34 lone AF tissues. We hypothesize that
this difference may be due to the high degree of selec-
tion of lone AF subjects in the cohort studied by Gollob.
In a prior analysis of Cx40 genetic variants using blood-
derived DNA, Yang and colleagues reported the discov-
ery of three nonsynonymous Cx40 variants in 218 lone
AF patients of Chinese descent, and no novel variants in
200 control subjects [26]. Our studies found no nonsy-
nonymous Cx40 variants in blood-derived DNA samples
from 91 lone AF subjects, which was not statistically dif-
ferent from the frequency observed by Yang. Combined
with our finding of no Cx40 nonsynonymous variants in
30 mixed AF atrial tissue samples, these results suggest
that Cx40 coding SNPs are uncommon in lone and sec-
ondary AF patient populations.
The current study has several limitations. First, all
samples were predominantly derived from patients of
European ancestry and the sample size was limited to
91 lone AF blood-derived DNA samples and 67 atrial
tissue samples, of which only 34 were lone AF subjects.
Second, we did not possess paired blood and tissue
samples, and thus were unable to determine whether
the rare GJA5 variants discovered in atrial tissue were
of germline or somatic origin. We also did not have a
large cohort of donor atrial tissue available that could
be used to compare the frequency of rare variants in
AF vs. control atria. Finally, our transfection study was
performed in HL-1 cells, an atrial-derived, immorta-
lized mouse cell line that demonstrates some atrial-like
properties [12]. It is therefore possible that the Cx40
30UTR insertion/deletion polymorphism, which we
observed to have no effect on reporter activity, could
still modify gene expression in vivo in the human
atrium.
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In 158 atria- and blood-derived DNA samples from sub-
jects with AF, we observed only one nonsynonymous
rare genetic variant in the GJA5 gene. We determined
that a 25 bp insertion-deletion polymorphism is com-
mon in the GJA5 30 UTR, but we could detect no func-
tional role for this variation. Our study suggests that
aggregations of different rare nonsynonymous GJA5 gen-
etic variants are not commonly observed among AF
patients. Although rare, GJA5 variants that alter Cx40
function may be directly causal of AF.
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